141 related articles for article (PubMed ID: 24980552)
1. IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers.
Marra P; Mathew S; Grigoriadis A; Wu Y; Kyle-Cezar F; Watkins J; Rashid M; De Rinaldis E; Hessey S; Gazinska P; Hayday A; Tutt A
Cancer Res; 2014 Sep; 74(17):4908-21. PubMed ID: 24980552
[TBL] [Abstract][Full Text] [Related]
2. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.
Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B
Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625
[TBL] [Abstract][Full Text] [Related]
3. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
5. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15
Borrelli C; Ricci B; Vulpis E; Fionda C; Ricciardi MR; Petrucci MT; Masuelli L; Peri A; Cippitelli M; Zingoni A; Santoni A; Soriani A
Cancer Immunol Res; 2018 Jul; 6(7):860-869. PubMed ID: 29691234
[TBL] [Abstract][Full Text] [Related]
7. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer.
Park IH; Yang HN; Lee KJ; Kim TS; Lee ES; Jung SY; Kwon Y; Kong SY
Oncotarget; 2017 May; 8(20):32722-32730. PubMed ID: 28415798
[TBL] [Abstract][Full Text] [Related]
10. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
Sami E; Paul BT; Koziol JA; ElShamy WM
Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
[TBL] [Abstract][Full Text] [Related]
11. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
13. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
Wu J; Sun Z; Sun H; Li Y
Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
[TBL] [Abstract][Full Text] [Related]
16. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
[TBL] [Abstract][Full Text] [Related]
17. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
[TBL] [Abstract][Full Text] [Related]
18. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
[No Abstract] [Full Text] [Related]
19. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
[TBL] [Abstract][Full Text] [Related]
20. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
